Protein Requirements for Active Children
Launched by ARKANSAS CHILDREN'S HOSPITAL RESEARCH INSTITUTE · Sep 28, 2020
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Protein Requirements for Active Children," is exploring how much protein healthy children aged 8 to 10 years need, especially those who are very active. Researchers believe that current guidelines for protein intake might be too low, particularly for kids who exercise a lot. To find out more, they will use a special method to measure how the body uses protein in children with different activity levels.
To be part of this study, children must be between 8 and 10 years old, healthy, and of normal weight. They should either be classified as active, getting more than an hour of exercise each day, or sedentary, getting less than that. Participants will need to stop taking certain nutritional supplements for two weeks before each testing visit. The trial is currently looking for participants, and children of all races and backgrounds are encouraged to join. Families can expect their children to undergo fitness tests and assessments related to their activity levels, helping researchers better understand the protein needs of active kids.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Inclusion Criteria
- • Boys or girls
- • Ages 8-10 years
- • All races
- • All ethnicities
- • Children who were determined to have normal weight (BMI \<85th percentile) already determined under Mitochondria (MI) Energy (IRB Protocol: 260376)
- • Participants willing to stop taking nutritional supplements (e.g., multivitamins, vitamin D, fish oil, probiotics, prebiotics, immune boosters, and others) for at least 2 weeks prior to each study testing visit
- • Children without an infection requiring antibiotics willing to be rescheduled after at least 2 months of finalizing antibiotic treatment.
- • Children without viral infections such as diarrhea, cold, or flu willing to be rescheduled after at least 2 weeks of resolution of symptoms.
- * Children determined sedentary or active, based on both peak oxygen uptake (VO2) and accelerometer data, as described below: Children who completed a peak fitness test during MI Energy (IRB Protocol: 260376), and for whom peak VO2 data are as follows:
- • Peak ⩒O2, ml·min-1·fat free mass index (FFMI)-1 Boys Girls Boys Girls
- • 89 ≤ 80 ≥115 ≥105 FFMI, fat-free mass index
- • AND
- Children who completed accelerometer measures during MI Energy (IRB Protocol: 260376), and for whom average daily activity counts and/or minutes of moderate to vigorous physical activity are as follow:
- • Sedentary Active Activity counts/day \<2,924,494 ≥3,767,075 Minutes of Moderate to vigorous physical activity/day \<60 ≥60
- • Children who completed National Survey of Children's Health and Youth Risk Behavior Survey (NSCH-YRBS) questionnaire during MI Energy study (IRB Protocol: 260376). Children who report ≥3 hours/day of Television (TV) (Sedentary) or ≤2 hours/day of TV (Active) will be considered
- • Children who completed Dual-energy x-ray absorptiometry (DXA) measures during MI Energy study (IRB Protocol: 260376)
- • Children whose parents consented to the following in the MI Energy study (IRB Protocol: 260376): o A) be contacted about future follow-up studies to MI Energy, and having the data that is collected about their child in MI Energy being used also in these follow-up studies; and
- • B) information collected in the MI Energy study may be used in future research related to bioenergetics (for example, blood cell mitochondria function), nutrition, obesity, cardiovascular health, or development; and
- • C) any biological samples collected in the MI Energy study may be used in future research related to bioenergetics (for example, blood cell mitochondria function), nutrition, obesity, cardiovascular health, or development.
- Exclusion Criteria:
- • • Participants who have been excluded from participation in the study MI Energy (IRB Protocol: 260376)
- • Participants whose parents report any change in medical history that may potentially affect participation and/or study outcomes as determined by PI
- • Weight loss \>3 kg in last 6 months
- • Taking medications that knowingly influences protein metabolism
- • Phenylketonuria
About Arkansas Children's Hospital Research Institute
The Arkansas Children's Hospital Research Institute (ACHRI) is a leading pediatric research organization dedicated to advancing child health through innovative scientific inquiry and clinical trials. As an integral part of Arkansas Children's, ACHRI focuses on a wide range of pediatric conditions, aiming to translate research findings into effective therapies and interventions. With a commitment to collaboration, ACHRI partners with academic institutions, healthcare providers, and industry leaders to enhance the understanding of childhood diseases and improve patient outcomes. Their research initiatives are guided by a patient-centered approach, ensuring that the needs and well-being of children remain at the forefront of their efforts.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Little Rock, Arkansas, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials